| Trial Identifier: | D7460C00002 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Altasciences Company Inc.
|
| NCTID:: | NCT05233085 |
| Start Date: | December 2021 |
| Primary Completion Date: | June 2022 |
| Study Completion Date: | June 2022 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| French (Canada) Translation |
| Country | Location |
|---|---|
| CA, QC | Laval, QC, CA, h7v 4bc |